FDA authorizes marketing for the eXiteOSA, a device intended to reduce snoring and mild obstructive sleep apnea in patients 18 years and older
Read more: FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older